BCR and B-cell chronic lymphocytic leukemia: Circulating CLL cells can also express pre‐activated VLA‐4 as a consequence of BCR‐autonomous triggering, further enhancing the binding of the serum VCAM‐1 and the subsequent survival effects [127].